Valhi Inc /de/
VALHI INC /DE/ operates in the Commodity & Specialty Chemicals industry, primarily generating revenue through the production and sale of chemical products, including titanium dioxide ("TiO2") operations under its subsidiary Kronos, and other industrial activities.
Business. Valhi Inc. is a Delaware-based company engaged in the commodity and specialty chemicals industry. The firm operates within the Basic Materials sector, specifically focusing on chemical products. It is publicly traded on the New York Stock Exchange under the ticker symbol VHI. Specific details regarding operating segments or geographic revenue breakdowns are not provided.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Valhi Inc. is a Delaware-based company engaged in the commodity and specialty chemicals industry. The firm operates within the Basic Materials sector, specifically focusing on chemical products. It is publicly traded on the New York Stock Exchange under the ticker symbol VHI. Specific details regarding operating segments or geographic revenue breakdowns are not provided.
VALHI's capital structure is characterized by a debt-to-equity ratio of 0.61, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 3.25, suggesting it can cover short-term obligations, but its operating cash flow of -$46.1 million and free cash flow of -$56.7 million indicate cash outflows in the most recent quarter. The market capitalization of $360.8 million and a price-to-earnings ratio of 180.41 suggest a high valuation relative to earnings, which may reflect market expectations of future performance or a lack of current profitability.
VALHI's profitability is weak, with a return on equity of 0.19% and a return on assets of 0.08%, both significantly below the industry median for Commodity & Specialty Chemicals. The company's operating margin of 5.84% (calculated from operating income of $32.9 million on revenue of $560.1 million) is also below the industry average, indicating that the company is not generating strong returns relative to its peers. The gross margin of 18.39% (calculated from gross profit of $103 million) is also below the industry median, suggesting that the company is facing cost pressures or pricing challenges.
VALHI's revenue is concentrated in a few key segments, with the majority of its operations centered around its subsidiary Kronos, which is a major producer of titanium dioxide. The company's geographic exposure is primarily in North America, with a significant portion of its operations located in the United States. The company's exposure to the titanium dioxide market, which is cyclical and subject to supply and demand fluctuations, is a key risk factor.
VALHI's growth trajectory is uncertain, with the company reporting a revenue of $560.1 million in Q1 2026. The outlook for the current fiscal year is not explicitly provided, but the company's historical performance and the industry's cyclical nature suggest that growth may be constrained. The company's capital expenditures of $10.6 million in the most recent quarter indicate a modest investment in growth, but the negative free cash flow suggests that the company is not generating sufficient cash to fund expansion without external financing.
VALHI faces several risk factors, including liquidity concerns due to negative operating and free cash flows, and the potential for dilution through future offerings or ATM programs. The company's risk assessment indicates a medium level of dilution risk, with the possibility of issuing additional shares to raise capital or settle liabilities. The company's exposure to litigation, particularly related to its former operations and environmental matters, is a significant risk that could impact its financial position and liquidity.
Recent events, including the company's history of acquisitions and divestitures, and the ongoing legal and environmental issues related to its former operations, have shaped its current financial and operational landscape. The company's recent filings highlight the potential for material adverse effects from the resolution of pending litigation and tax examinations, which could impact its financial statements and liquidity.
- VALHI's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.61, but its liquidity is constrained by negative operating and free cash flows.
- The company's profitability is weak, with a return on equity of 0.19% and a return on assets of 0.08%, both below the industry median.
- VALHI's revenue is concentrated in its titanium dioxide operations, which are subject to cyclical market conditions and supply and demand fluctuations.
- The company's growth trajectory is uncertain, with negative free cash flow and modest capital expenditures indicating limited internal funding for expansion.
- VALHI faces significant risk factors, including liquidity concerns, potential dilution, and exposure to litigation and environmental matters.
- Recent events, including legal and environmental issues, have shaped the company's financial and operational landscape, with potential material adverse effects on its financial position and liquidity.
Bull / Bear case
Generated · model-assistedValhi generated $108 million in net income for FY2024, representing a significant profitability turnaround from the prior year's loss.
Operating income surged 232.9% year-over-year to $210.7 million in FY2024, demonstrating strong operational leverage and margin expansion.
The company reduced long-term debt to $484.4 million in FY2024, improving its balance sheet strength compared to the previous year.
Free cash flow improved by 116.0% year-over-year to $13.1 million in FY2024, signaling enhanced cash generation capabilities.
Valhi faces high credit risk and medium dilution risk, posing significant threats to shareholder value and financial stability.
Cash conversion stands at -23.05%, placing Valhi in the bottom quartile of its commodity and specialty chemicals cohort.
Interest coverage ratio of 1.11 indicates limited buffer for servicing debt obligations, heightening financial vulnerability during downturns.
FY2025 projections show a net loss of $57.6 million and negative free cash flow of $82.1 million, indicating near-term volatility.
In focus — financials by report
Revenue $560.1M; Operating income $32.9M.
- ▍Revenue $560.1M
- ▍Operating income $32.9M
- ▍Net margin 0.4%
Revenue $1.58B; Operating income $94.2M.
- ▍Revenue $1.58B
- ▍Operating income $94.2M
- ▍Net margin -0.3%
Revenue $1.08B; Operating income $85.6M.
- ▍Revenue $1.08B
- ▍Operating income $85.6M
- ▍Net margin 1.6%
Revenue $2.08B; Operating income $63.3M.
- ▍Revenue $2.08B
- ▍Operating income $63.3M
- ▍Net margin -2.8%
Revenue $2.10B; Operating income $210.7M.
- ▍Revenue $2.10B
- ▍Operating income $210.7M
- ▍Net margin 5.1%
Revenue $2.10B; Operating income $210.7M.
- ▍Revenue $2.10B
- ▍Operating income $210.7M
- ▍Net margin 5.1%
Revenue $1.92B; Operating income $34.2M.
- ▍Revenue $1.92B
- ▍Operating income $34.2M
- ▍Net margin -0.6%
Revenue $1.92B; Operating income $34.2M.
- ▍Revenue $1.92B
- ▍Operating income $34.2M
- ▍Net margin -0.5%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
- Source documents mention dilution or offering risk.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Regulatory filings
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- VALHI INC /DE/ company facts · 2026-05-31
- VALHI INC /DE/ 10-Q 2026-05-07 · 2026-05-31
- VALHI INC /DE/ 10-K 2026-03-10 · 2026-05-31
- VALHI INC /DE/ 10-Q 2025-11-06 · 2026-05-31
- VALHI INC /DE/ 10-Q 2025-08-07 · 2026-05-31
Ownership & reference
Top holders
- Institutional Investor · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2024-06-300,00 %$3M
- Investment Managers · as of 2024-12-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2025-12-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Insider activity
- Director · Common Stock $0.01 par value per shareOther 3 150 @ $12,66$40K · 2026-05-21
- Director · Common Stock $0.01 par value per shareOther 3 150 @ $12,66$40K · 2026-05-21
- Director · Common Stock $0.01 par value per shareOther 3 150 @ $12,66$40K · 2026-05-21
- Director · Common Stock $0.01 par value per shareOther 3 150 @ $12,66$40K · 2026-05-21
- Director · Common Stock $0.01 par value per shareOther 3 150 @ $12,66$40K · 2026-05-21
- Director · Common Stock $0.01 par value per shareOther 3 150 @ $12,66$40K · 2026-05-21
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Return on equity (FY 2025-12-31): -5.6%Derived (calculated)
- Net margin (FY 2025-12-31): -2.8%Derived (calculated)
- Gross margin (FY 2025-12-31): 14.2%Derived (calculated)
- Return on assets (FY 2025-12-31): -2.2%Derived (calculated)
- Current ratio (FY 2025-12-31): 2.80xDerived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): 50.8%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -38.6%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 6.0%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -153.3%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -153.3%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): -30.4%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -153.3%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -180.7%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -70.0%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 21.4%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): -1.3%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -1.2%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -6.0%Derived (calculated)
- Gross profit (annual): USD 295.4MSEC XBRL filing
- Operating cash flow (annual): USD -35.5MSEC XBRL filing
- R&D expense (annual): USD 17MSEC XBRL filing
- Shareholders' equity (annual): USD 1.02BSEC XBRL filing
- Total assets (annual): USD 2.63BSEC XBRL filing
- Shares outstanding (annual): 29.6MSEC XBRL filing